Related Experiment Videos
[Congestive cardiomyopathy after a 10-year observation]
T Petelenz1, I Axenti, B Gabrylewicz
1III Kliniki Kardiologii Slaskiej AM w Katowicach.
Insights
This study analyzed 44 patients with congestive cardiomyopathy, comparing primary and secondary causes. It evaluated non-invasive diagnostics and treatment effectiveness in Polish cardiosurgery patients.
Area of Science:
- Cardiology
- Internal Medicine
Context:
- Analysis of patients with congestive cardiomyopathy in Poland (1980-1989).
- Focus on non-invasive diagnostic techniques and treatment outcomes.
- Involved 44 patients from the III Department of Cardiology in Katowice-Ochojec.
Purpose:
- To analyze patients with congestive cardiomyopathy diagnosed using non-invasive techniques.
- To evaluate the dynamics of the disease and treatment effectiveness.
- To compare results between primary and secondary cardiomyopathy groups.
Summary:
- The study included 44 patients, with 66% being men. Half had unknown etiology (primary cardiomyopathy), while the other half had secondary causes like infections or ischemic heart disease.
- Non-invasive diagnostic procedures and clinical status were analyzed from therapy initiation to the end of 1989.
- Treatment effectiveness and disease progression were evaluated, with direct causes of death investigated and compared between the two groups.
Impact:
- Provides insights into congestive cardiomyopathy diagnosis and management in Poland.
- Highlights the importance of non-invasive techniques in assessing cardiac conditions.
- Contributes to understanding the etiological factors and outcomes in cardiomyopathy patients.
Abstract:
A progress in the Polish cardiosurgery promising survival has led to the analysis of patients with congestive cardiomyopathy diagnosed with non-invasive techniques. The study involved 44 patients treated at the III Department of Cardiology in Katowice-Ochojec in 1980-1989. Sixty six percent of these patients were men. Etiology remained unknown in half of them, suggesting the primary cardiomyopathy (group I). As a cause of the secondary cardiomyopathy (group II) infections were considered (bacterial, fungal, and tuberculous), systemic diseases, and ischemic heart disease. Clinical status and results of all non-invasive diagnostic procedures performed since the beginning of therapy to the end of 1989 were analysed. Ultimate examination were performed at the Voivodeship Cardiologic Out-patient Clinic. Dynamics of the disease and effectiveness of the treatment were evaluated. In case of death its direct cause was sought. All results were compared in both groups.